STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing

Journal of Experimental Medicine

Volumn 206, Issue 7, 2009, Pages 1465-1472

  Pickert, Geethanjali ^a   Neufert, Clemens ^a   Leppkes, Moritz ^a   Zheng, Yan ^c   Wittkopf, Nadine ^a   Warntjen, Moritz ^a   Lehr, Hans Anton ^b   Hirth, Sebastian ^a   Weigmann, Benno ^a   Wirtz, Stefan ^a   Ouyang, Wenjun ^c   Neurath, Markus F ^d   Becker, Christoph ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

^c GENENTECH INC   (United States)

^d UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; INTERLEUKIN 22; INTERLEUKIN 6; STAT3 PROTEIN; TOLL LIKE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELLULAR STRESS RESPONSE; COLITIS; CONTROLLED STUDY; GENETIC ANALYSIS; GENETIC ENGINEERING; HOMEOSTASIS; INTESTINE EPITHELIUM CELL; KNOCKOUT MOUSE; MOUSE; MUCOSA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; WOUND HEALING;

ANIMALS; COLITIS; DEXTRAN SULFATE; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; INFLAMMATION; INTERLEUKIN-6; INTERLEUKINS; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; WOUND HEALING;

EID: 67650474246     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20082683     Document Type: Article

References (30)

1. Akira, S. 2000. Roles of STAT3 defined by tissue-specific gene targeting. Oncogene. 19:2607-2611.
2. Alonzi, T., I.P. Newton, P.J. Bryce, E. Di Carlo, G. Lattanzio, M. Tripodi, P. Musiani, and V. Poli. 2004. Induced somatic inactivation of STAT3 in mice triggers the development of a fulminant form of enterocolitis. Cytokine. 26:45-56.
3. Atreya, R., J. Mudter, S. Finotto, J. Mullberg, T. Jostock, S. Wirtz, M. Schutz, B. Bartsch, M. Holtmann, C. Becker, et al. 2000. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo. Nat. Med. 6:583-588.
4. Becker, C., M.C. Fantini, C. Schramm, H.A. Lehr, S. Wirtz, A. Nikolaev, J. Burg, S. Strand, R. Kiesslich, S. Huber, et al. 2004. TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity. 21:491-501.
5. Becker, C., M.C. Fantini, S. Wirtz, A. Nikolaev, R. Kiesslich, H.A. Lehr, P.R. Galle, and M.F. Neurath. 2005. In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy. Gut. 54:950-954.
6. Bollrath, J., T.J. Phesse, V.A. von Burstin, T. Putoczki, M. Bennecke, T. Bateman, T. Nebelsiek, T. Lundgren-May, O. Canli, S. Schwitalla, et al. 2009. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell. 15:91-102.
7. Brand, S., F. Beigel, T. Olszak, K. Zitzmann, S.T. Eichhorst, J.M. Otte, H. Diepolder, A. Marquardt, W. Jagla, A. Popp, et al. 2006. IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am. J. Physiol. Gastrointest. Liver Physiol. 290:G827-G838.
8. Cella, M., A. Fuchs, W. Vermi, F. Facchetti, K. Otero, J.K. Lennerz, J.M. Doherty, J.C. Mills, and M. Colonna. 2009. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature. 457:722-725.
9. Chapman, R.S., P. Lourenco, E. Tonner, D. Flint, S. Selbert, K. Takeda, S. Akira, A.R. Clarke, and C.J. Watson. 2000. The role of Stat3 in apoptosis and mammary gland involution. Conditional deletion of Stat3. Adv. Exp. Med. Biol. 480:129-138.
10. Grivennikov, S., E. Karin, J. Terzic, D. Mucida, G.Y. Yu, S. Vallabhapurapu, J. Scheller, S. Rose-John, H. Cheroutre, L. Eckmann, and M. Karin. 2009. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 15:103-113.
11. Levy, D.E., and J.E. Darnell Jr. 2002. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3:651-662.
12. Liu, X., Y.S. Lee, C.R. Yu, and C.E. Egwuagu. 2008. Loss of STAT3 in CD4+ T cells prevents development of experimental autoimmune diseases. J. Immunol. 180:6070-6076.
13. Lovato, P., C. Brender, J. Agnholt, J. Kelsen, K. Kaltoft, A. Svejgaard, K.W. Eriksen, A. Woetmann, and N. Odum. 2003. Constitutive STAT3 activation in intestinal T cells from patients with Crohn's disease. J. Biol. Chem. 278:16777-16781.
14. Madison, B.B., L. Dunbar, X.T. Qiao, K. Braunstein, E. Braunstein, and D.L. Gumucio. 2002. Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine. J. Biol. Chem. 277:33275-33283.
15. Mudter, J., B. Weigmann, B. Bartsch, R. Kiesslich, D. Strand, P.R. Galle, H.A. Lehr, J. Schmidt, and M.F. Neurath. 2005. Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases. Am. J. Gastroenterol. 100:64-72.
16. Nenci, A., C. Becker, A. Wullaert, R. Gareus, G. van Loo, S. Danese, M. Huth, A. Nikolaev, C. Neufert, B. Madison, et al. 2007. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature. 446:557-561.
17. Ouyang, W., J.K. Kolls, and Y. Zheng. 2008. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity. 28:454-467.
18. Pull, S.L., J.M. Doherty, J.C. Mills, J.I. Gordon, and T.S. Stappenbeck. 2005. Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc. Natl. Acad. Sci. USA. 102:99-104.
19. Reinecker, H.C., M. Steffen, T. Witthoeft, I. Pflueger, S. Schreiber, R.P. MacDermott, and A. Raedler. 1993. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin. Exp. Immunol. 94:174-181.
20. Rescigno, M. 2008. The pathogenic role of intestinal flora in IBD and colon cancer. Curr. Drug Targets. 9:395-403.
21. Rimoldi, M., M. Chieppa, V. Salucci, F. Avogadri, A. Sonzogni, G.M. Sampietro, A. Nespoli, G. Viale, P. Allavena, and M. Rescigno. 2005. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat. Immunol. 6:507-514.
22. Strober, W., I. Fuss, and P. Mannon. 2007. The fundamental basis of inflammatory bowel disease. J. Clin. Invest. 117:514-521.
23. Sugimoto, K., A. Ogawa, E. Mizoguchi, Y. Shimomura, A. Andoh, A.K. Bhan, R.S. Blumberg, R.J. Xavier, and A. Mizoguchi. 2008. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J. Clin. Invest. 118:534-544.
24. Takeda, K., T. Kaisho, N. Yoshida, J. Takeda, T. Kishimoto, and S. Akira. 1998. Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J. Immunol. 161:4652-4660.
25. Takeda, K., B.E. Clausen, T. Kaisho, T. Tsujimura, N. Terada, I. Forster, and S. Akira. 1999. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity. 10:39-49.
26. Welte, T., S.S. Zhang, T. Wang, Z. Zhang, D.G. Hesslein, Z. Yin, A. Kano, Y. Iwamoto, E. Li, J.E. Craft, et al. 2003. STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity. Proc. Natl. Acad. Sci. USA. 100:1879-1884.
27. Wolk, K., and R. Sabat. 2006. Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev. 17:367-380.
28. Zenewicz, L.A., G.D. Yancopoulos, D.M. Valenzuela, A.J. Murphy, S. Stevens, and R.A. Flavell. 2008. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity. 29:947-957.
29. Zheng, Y., D.M. Danilenko, P. Valdez, I. Kasman, J. Eastham-Anderson, J. Wu, and W. Ouyang. 2007. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature. 445:648-651.
30. Zheng, Y., P.A. Valdez, D.M. Danilenko, Y. Hu, S.M. Sa, Q. Gong, A.R. Abbas, Z. Modrusan, N. Ghilardi, F.J. de Sauvage, and W. Ouyang. 2008. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14:282-289.